51 results
10-K
2023 FY
EX-10.18
XLO
Xilio Therapeutics Inc
Annual report
1 Apr 24
4:20pm
8-K
EX-10.2
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
10-Q
2023 Q3
EX-10.3
XLO
Xilio Therapeutics Inc
Quarterly report
9 Nov 23
4:17pm
8-K
EX-10.1
aexw3
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
EX-10.1
6txmnae jii
3 Aug 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.1
42aegok vxs949
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
ccnx3 ya7oz
16 Jun 22
Departure of Directors or Certain Officers
7:45am
10-K
EX-10.20
bpuqt
1 Mar 22
Annual report
4:07pm
S-1/A
EX-10.8
vnn5cgl
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.5
08jzgim fhbr
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.6
xvuwropnkg2vgg2d
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.19
q6egxq74n
18 Oct 21
IPO registration (amended)
6:04am